NCT04126096View on ClinicalTrials.gov

Negative Predictive Value and NIC of Beta-Lactam Antibiotics.

NACompletedINTERVENTIONAL
Enrollment

747

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

January 6, 2023

Study Completion Date

January 6, 2023

Conditions
Allergy
Interventions
DIAGNOSTIC_TEST

Skin Testing beta-lactams

Percutaneous skin prick followed by Intradermal Injections of NMBAs at increasing concentrations compared with an established positive and negative control.

Trial Locations (2)

32224

Mayo Clinic in Florida, Jacksonville

Mayo Clinic, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04126096 - Negative Predictive Value and NIC of Beta-Lactam Antibiotics. | Biotech Hunter | Biotech Hunter